Gopalakrishna et al. [54] explained the U-shaped dose–response effects by elucidating how selenium binds to PKC at lower concentrations, inactivating the anti-apoptotic enzyme PKC and promoting the peroxyhydrogen reaction of tumor lipids. This evidence concerns the gene PRRT2 and neoplasm.